Mylan Can't Escape EpiPen Distributors' Antitrust Claims
By Khorri Atkinson · January 19, 2021, 6:06 PM EST
A Minnesota federal judge has refused to throw out a proposed class action that accuses drugmaker Mylan Inc. of paying bribes and kickbacks to a group of pharmacy benefit managers and...
To view the full article, register now.